Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers
Clinical trial NCT00933062 · COMPLETED
Trial details
- NCT number
- NCT00933062
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-23
- Primary completion
- 2009-05-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.